English

Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

询价与订购

  • Name*

  • Phone*

  • Email*

  • Product*

  • Content*

Anti-APP重组抗体|科研级 Donanemab (多奈单抗 )

CatNo:TKYR1541

  • 1mg
  • 5mg
WeChat QR
Contact Us
instructions
MSDS
WeChat QR
Contact Us
  • Detailed
  • Background
  • Plan&FAQ
  • Related
  • Recommended
  • Detailed related information

    Catalog Number

    TKYR1541

    Alias

    科研级 Donanemab (多奈单抗 ), Anti-APP Recombinant Antibody, Research Grade Donanemab

    Molecular Name

    Donanemab

    Size

    1mg, 5mg

    CAS Number

    1931944-80-7

    Isotype

    IgG1 Kappa

    Clonality

    Monoclonal

    Concentration

    1mg/ml

    Source

    CHO Cells

    Purity

    ≥95% as determined by SDS-PAGE

    Buffer

    Supplied in PBS, PH7.5

    Target

    APP[Homo sapiens]

    Background

    Donanemab (USAN, development code LY3002813) is a biological drug in trial to treat early symptoms of Alzheimer's disease. There is no cure or treatment for Alzheimer’s disease. Donanemab has shown positive results in Eli Lilly and Co.’s first two trials.

    Storage

    该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。

    NOTE

    仅科研使用
    Target background information
    Experimental Plan&FAQ

    To experience the reliable service of Tekbiotech please subscribe: